Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06058104 · ClinicalTrials.gov registry record · NA

Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism

A NA study, sponsored by Stanford University.

Not yet
Registry status
NA
Development phase
1,000
Enrollment target

NCT06058104: Clinical Trial NA study, sponsored by Stanford University.

NCT06058104 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06058104, a NA study, has not yet begun recruiting, sponsored by Stanford University.

NOT YET RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

The following study aims to assess the efficacy of the game-based digital therapeutic, GuessWhat, in improving adaptive socialization skills in children with Autism Spectrum Disorder (ASD). GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pro-social charades, emotion guessing, and quiz. Participant families will use their personal smartphones to download the app and play it with their child according to a predetermined regimen.

Primary Outcome

Vineland Adaptive Behavior Scales, 3rd edition (VABS-3) Socialization subscale of the Parent/Caregiver Comprehensive form will be administered online to the parents. Scores from the socialization domain of the VABS-III reflects one's functioning in social situations. The socialization subscale is up to 112 items depending on age and development, where raw scores are converted to Intellectual Quotient-type standard scores--v-scale scores (M=15, SD=3) where scores range from 1 to 24, and factor in

Interventions

  • DEVICE Charades based mobile digital therapeutic

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-10
Est. Completion 2026-12
Phase NA
Stanford University

1,744 total trials

What is known before NCT06058104 opens enrollment

NCT06058104 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 0 conditions, and to 1 intervention - of which Charades based mobile digital therapeutic is the first listed.

NCT06058104 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06058104 about?

NCT06058104 is a clinical study titled "Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism". The following study aims to assess the efficacy of the game-based digital therapeutic, GuessWhat, in improving adaptive socialization skills in children with Autism Spectrum Disorder (ASD). GuessWhat is a mobile application (available for free for iOS and Android) which contains a suite of games: pr...

What is the current status of trial NCT06058104?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-10. Estimated completion is 2026-12.

What interventions are being tested in trial NCT06058104?

The interventions under investigation include: Charades based mobile digital therapeutic (DEVICE).

Who is sponsoring clinical trial NCT06058104?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06058104's enrollment target sits among peer trials

1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06058104, the US trial registry maintained by the National Library of Medicine. NCT06058104 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.